HIPK2 and malignant colon neoplasm: Using part of the above TMA of primary human colon tumor samples [70], the authors analyzed 84 patients with stage II colon cancer, treated or not with adjuvant chemotherapy, to evaluate the contribution of HIPK2 in chemotherapy response [71].